One Eleven Interactive, Inc

Innovative marketing programs for the pharmaceutical industry

One Eleven Interactive, Inc Pharmaceuticals How to spot an antibiotic resistance scare in Canada

How to spot an antibiotic resistance scare in Canada



There are some concerns the government could be facing an antibiotic outbreak after all.

It seems it’s a scenario that’s being considered by many health authorities around the country.

As it stands, Canada has only one approved antibiotic and it’s called rifampicin.

The drug is used to treat infections such as pneumonia, urinary tract infections, gonorrhea and HIV, among others.

But the Canadian Food Inspection Agency says that while rifamivir is used in the treatment of serious infections, it’s also commonly used in food preparation.

“Rifampin is a common ingredient in food prepared for human consumption, and can cause resistance in bacteria, including some bacteria resistant to antibiotics,” says Dr. Chris Jansen, the FDA’s chief medical officer.

“So it’s not a complete cure, but it’s one way to control infections.”

Rifamir is currently available in the U.S. and Canada, but is not approved for human use in the European Union.

And there’s a lot of skepticism about whether the FDA can adequately test the drug for its potential resistance.

Jansen says the FDA is also working on a plan to test a new antibiotic called cephalosporin, which is used as a treatment for gonorrheal infections, to see if it could be a possible cause of resistance.

But it’s unclear if cepherosporins resistance is a real possibility.

A new report from researchers at the University of British Columbia and the University at Buffalo is suggesting the same problem is at play.

They say the problem is a “hidden” one that may not even be visible to the public.

“We believe this problem is more widespread than we realized and that there are still opportunities to address it without having to make a rash of panic and panic over a potentially non-infectious organism,” they write in a paper.

“The real problem is not only that antibiotic resistance exists but that resistance to these agents may be hidden in the population.”

In other words, it may be possible to test the antibiotics for resistance without worrying about a pandemic outbreak, because resistance is often hard to spot in the first place.

In their paper, the researchers say that while it’s important to be cautious about relying on public health measures to stop the spread of resistance, they do believe there is an opportunity to find a solution.

“The real question is whether this will be a public health problem and how we can do the right thing and protect our own community,” they wrote.

TopBack to Top